Targeted Delivery for Customized Cancer Care
MediChip™️ is a delivery platform designed to deliver drugs directly onto a local site, with an initial indication for treating locally advanced unresectable tumor(s).
The Market
$
0
Billion
Spent on Cancer Care in America in 2020
$
0
Billion
Expected to be spent on Cancer Care in America by 2030
$
0
Billion
Cost of Colorectal Cancer Care in America in 2020
Cancer
The Problem, Impact & Cause.
Cancer is a terrifying diagnosis and the treatment, far worse. Systemic intravenous (IV) chemotherapy is unable to discriminate between healthy
and tumorous cells, thus indiscriminately destroying both of them.
The most common side effect for patients include nausea/vomiting due to
damage to GI cells, hair loss due to hair follicle death, myelosuppression
(decreased immunity) leading to a poor quality of life.
Biosapien Solution
MediChip®
MediChip™️ is indicated for use as a treatment to prevent major life-altering surgeries in patients with recurrent locally advanced malignancies. The goal is to deliver an active pharmaceutical ingredient directly to the site of the tumor while minimizing dose-limiting systemic toxicity.
BioSapien™️’s technology offers a joint solution to the problems of surgery and chemotherapy and can be delivered in parallel with standard of care.
Let’s Change Treatment
Developing Innovative Therapies to Transform Patient Care
- 10210 Campus Point Dr, Suite 150 San Diego, CA 92121
- hello@biosapien.com
Links
Menu
Stay Connected
Join the BioSapien™ Mailing List
© 2022 Biosapien | All Rights Reserved
Powered By
